High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|June 3, 2019
- The Column-06-04-2019
- Volume 15
- Issue 6
Vol 15 No 6 The Column June 2019 North American PDF
Click the title above to open The Column June 2019 North American issue, Volume 15, Number 6, in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Vol 15 No 6 The Column June 2019 Europe & Asia PDFover 7 years ago
A Design for Life Sciencesover 7 years ago
Need a New Instrument to Innovate?over 7 years ago
Refining Nucleic Acid Characterization Using HILIC–MSover 7 years ago
The LCGC Blog: Forensic Drug Analysis: GC–MS versus LC–MSAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
5